Smith Wilbur III Buys Shares of American Healthcare REIT
Smith Wilbur III acquired 2,594 shares of American Healthcare REIT on June 24, 2026.
Key Points
- Smith Wilbur III purchased 2,594 shares of American Healthcare REIT (NYSE:AHR) on June 24, 2026.
- Shares of AHR traded near $51.48 on Saturday, with a market cap of about $10.53 billion and a P/E ratio of 86.3.
- Analysts maintain a strong buy consensus with a mean target price of $58.23 for AHR.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Smith Wilbur III bought 2,594 shares of American Healthcare REIT, Inc. (NYSE:AHR) on June 24, 2026. This insider buying activity comes as the company's stock traded near $51.48 on Saturday.
Insider Buying and Selling at American Healthcare REIT, Inc.
Several insiders, including Smith Wilbur III, acquired 2,594 shares each of American Healthcare REIT on June 24, 2026. These transactions were not part of any pre-planned trading programs, suggesting a personal investment decision.
American Healthcare REIT, Inc. Stock Down 8.2%
Shares of NYSE:AHR traded close to $51.48 on Saturday. American Healthcare REIT has a market cap of approximately $10.53 billion, a P/E ratio of 86.3, and a forward P/E of 59.2. Its beta of 0.805 indicates lower volatility compared to the broader market. The stock's 52-week range spans from $35.52 to $54.67, with a 50-day moving average of $49.15 and a 200-day moving average of $47.81.
$AHR stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 18, 2026, Scotiabank maintained its buy rating for American Healthcare REIT with a target price of $51. Keybanc and RBC Capital also maintained their buy ratings with target prices of $58 and $56, respectively, in May 2026. The consensus among analysts is a strong buy, with a mean price target of $58.23 among 13 analysts.
About American Healthcare REIT
American Healthcare REIT, Inc. is a self-managed real estate investment trust based in Irvine, California. The company owns and operates a diverse portfolio of healthcare-related properties across the United States, the United Kingdom, and the Isle of Man. Its assets include senior housing, skilled nursing facilities, and outpatient medical buildings. Led by CEO Jeffrey T. Hanson, the firm employs 121 people and focuses on income-generating assets and selective development projects.
Bottom Line
Smith Wilbur III's purchase of American Healthcare REIT shares adds to the insider activity at the company, signaling potential confidence in its prospects. With a strong buy consensus from analysts and a robust portfolio of healthcare properties, American Healthcare REIT remains a company to watch. As always, remember that insider transactions and analyst ratings are just pieces of the puzzle and should be considered alongside other factors.
Get American Healthcare REIT, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AHR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
